Next Level Private’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$869K Sell
725
-16
-2% -$16.3K 0.17% 86
2026
Q1
$682K Buy
741
+18
+2% +$18.2K 0.15% 91
2025
Q4
$777K Buy
723
+8
+1% +$7.65K 0.2% 84
2025
Q3
$605K Buy
715
+6
+0.8% +$4.46K 0.18% 87
2025
Q2
$553K Buy
709
+2
+0.3% +$1.55K 0.18% 84
2025
Q1
$584K Buy
707
+1
+0.1% +$832 0.22% 79
2024
Q4
$545K Hold
706
0.22% 75
2024
Q3
$625K Buy
706
+6
+0.9% +$5.39K 0.26% 72
2024
Q2
$634K Buy
700
+4
+0.6% +$3.2K 0.29% 66
2024
Q1
$541K Buy
696
+241
+53% +$172K 0.25% 72
2023
Q4
$265K Sell
455
-47
-9% -$27.4K 0.15% 90
2023
Q3
$270K Buy
502
+49
+11% +$25.2K 0.18% 81
2023
Q2
$205K Buy
+453
New +$190K 0.13% 99

Other funds holding LLY

Next Level Private's LLY Position: Q2 2026 in Review

Next Level Private reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2026, selling an estimated $16.3K and leaving 725 shares worth $869K. The position accounts for 0.17% of the portfolio, ranked #86.

Next Level Private first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Next Level Private held 725 shares of Eli Lilly worth $869K as of Q2 2026.
  • Next Level Private sold 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
  • Eli Lilly made up 0.17% of Next Level Private's portfolio in Q2 2026, its #86 holding.
  • Next Level Private first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Next Level Private's 13F filing for Q2 2026, filed 9 Jul 2026.